aflunov
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2008 (NCT00814385)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- aflunov
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00814385 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2008 | Medical Research Council, Novartis, Public Health England, University of Leicester |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medical Research Council | Government | 1 | 0 | 1 | 2008 |
| Novartis | For profit | 1 | 0 | 1 | 2008 |
| Public Health England | Government | 1 | 0 | 1 | 2008 |
| University of Leicester | Academic/Hospital | 1 | 1 | 1 | 2008 |
4 organizations
Page 1 / 1